New England Biolabs, announced the launch of the NEBNext Enzymatic 5hmC-seq Kit a novel enzyme-based method for the specific detection of 5hmC sites. The gentle,...
AbbVie, announced that it has completed its acquisition of ImmunoGen. With the completion of the acquisition, ImmunoGen is now part of AbbVie.
"Together with ImmunoGen,...
Iambic Therapeutics, a biotechnology company developing novel therapeutics using its AI-driven discovery platform, announced the appointment of oncologist and industry veteran Neil Josephson, M.D.,...
Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, has announced the launch of its new analytical platform, LabZient. The standardized and automated platform...
